

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.38031244 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.09732264 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.09732264 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.96197070 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88842998 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.44364200 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.37647461 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.25217733 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.19871144 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 4.12845488 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.06123768 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.06123768 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.06123768 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.06123768 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.06123768 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.06123768 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.05778509 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.92520734 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92197242 |
| 20 | cellular response to interleukin-15 (GO:0071350) | 3.91157562 |
| 21 | negative T cell selection (GO:0043383) | 3.90333888 |
| 22 | response to interleukin-15 (GO:0070672) | 3.90306026 |
| 23 | cellular extravasation (GO:0045123) | 3.81024082 |
| 24 | neutrophil mediated immunity (GO:0002446) | 3.73571663 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.72616586 |
| 26 | negative regulation of T cell mediated immunity (GO:0002710) | 3.67942731 |
| 27 | neutrophil activation (GO:0042119) | 3.65254707 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.63248394 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.61819291 |
| 30 | response to peptidoglycan (GO:0032494) | 3.59896849 |
| 31 | microglial cell activation (GO:0001774) | 3.58324467 |
| 32 | detection of other organism (GO:0098543) | 3.56499990 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.44806465 |
| 34 | T cell migration (GO:0072678) | 3.44124742 |
| 35 | response to type I interferon (GO:0034340) | 3.43061141 |
| 36 | detection of bacterium (GO:0016045) | 3.42846405 |
| 37 | type I interferon signaling pathway (GO:0060337) | 3.41268337 |
| 38 | cellular response to type I interferon (GO:0071357) | 3.41268337 |
| 39 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.39204664 |
| 40 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.38892426 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.37325998 |
| 42 | respiratory burst (GO:0045730) | 3.32545222 |
| 43 | activated T cell proliferation (GO:0050798) | 3.31057901 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.27415479 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26987460 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.26377546 |
| 47 | granulocyte activation (GO:0036230) | 3.25457760 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.23371143 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.23049136 |
| 50 | positive regulation of mast cell activation (GO:0033005) | 3.23034507 |
| 51 | regulation of antigen processing and presentation (GO:0002577) | 3.22999419 |
| 52 | tolerance induction (GO:0002507) | 3.21845859 |
| 53 | interferon-gamma production (GO:0032609) | 3.20344557 |
| 54 | leukocyte aggregation (GO:0070486) | 3.20239376 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.18693680 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.17239045 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17214165 |
| 58 | response to host immune response (GO:0052572) | 3.17214165 |
| 59 | defense response to protozoan (GO:0042832) | 3.16301300 |
| 60 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.12294733 |
| 61 | myeloid leukocyte mediated immunity (GO:0002444) | 3.11633924 |
| 62 | regulation of mast cell activation (GO:0033003) | 3.09020180 |
| 63 | leukocyte degranulation (GO:0043299) | 3.08570855 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07712524 |
| 65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06946662 |
| 66 | T cell selection (GO:0045058) | 3.04949060 |
| 67 | response to protozoan (GO:0001562) | 3.04827295 |
| 68 | positive regulation of defense response to virus by host (GO:0002230) | 3.00561091 |
| 69 | detection of external biotic stimulus (GO:0098581) | 2.96956796 |
| 70 | mast cell activation (GO:0045576) | 2.96140679 |
| 71 | positive thymic T cell selection (GO:0045059) | 2.95647673 |
| 72 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94624756 |
| 73 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.94072562 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92033790 |
| 75 | DNA deamination (GO:0045006) | 2.91273018 |
| 76 | B cell mediated immunity (GO:0019724) | 2.90593423 |
| 77 | positive T cell selection (GO:0043368) | 2.88896372 |
| 78 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87861429 |
| 79 | regulation of T cell tolerance induction (GO:0002664) | 2.87430747 |
| 80 | dendritic cell migration (GO:0036336) | 2.85258761 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.83591228 |
| 82 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.83481632 |
| 83 | macrophage activation (GO:0042116) | 2.82498186 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.82431708 |
| 85 | regulation of interferon-alpha production (GO:0032647) | 2.82258056 |
| 86 | positive regulation of interferon-alpha production (GO:0032727) | 2.80256211 |
| 87 | detection of molecule of bacterial origin (GO:0032490) | 2.79881525 |
| 88 | response to host (GO:0075136) | 2.78168901 |
| 89 | response to host defenses (GO:0052200) | 2.78168901 |
| 90 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.78168901 |
| 91 | regulation of interleukin-12 production (GO:0032655) | 2.76178316 |
| 92 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.75863561 |
| 93 | cytidine metabolic process (GO:0046087) | 2.74839673 |
| 94 | cytidine catabolic process (GO:0006216) | 2.74839673 |
| 95 | cytidine deamination (GO:0009972) | 2.74839673 |
| 96 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.73764921 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.73764921 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 2.73465933 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.72987747 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 2.72695931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.80728411 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.25956978 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.19492691 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88018854 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.56259319 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.37061656 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06024933 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.95116277 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.92328332 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.81480408 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54286850 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.52876887 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.49540436 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42014901 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.32433454 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.27532940 |
| 17 | GATA3_26560356_Chip-Seq_TH2_Human | 2.15647417 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.09500936 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00657423 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 1.96310372 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94736111 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.93830029 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.91961088 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91371739 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90912933 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86366030 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83799940 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79414934 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.75966907 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74283954 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67955646 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.64353682 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63514181 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60136067 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55392935 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53995753 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53670168 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50728351 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49499838 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46314238 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40812180 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38241903 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32230279 |
| 44 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.32098035 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29588414 |
| 46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28288030 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27125234 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25910772 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23200840 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.18071347 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16932771 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16876902 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16358670 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.11636722 |
| 55 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11629422 |
| 56 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.10148972 |
| 57 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07825174 |
| 58 | GATA3_26560356_Chip-Seq_TH1_Human | 1.07265807 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07037109 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06733253 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05953209 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05837897 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02728255 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02104308 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02095820 |
| 66 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00839136 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98260973 |
| 68 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98043572 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97829412 |
| 70 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96029180 |
| 71 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95709305 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95033153 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93496843 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92939210 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92930430 |
| 76 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.91455687 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90915304 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90681376 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89949256 |
| 80 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88827821 |
| 81 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87675291 |
| 82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87514893 |
| 83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85747632 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 0.85706801 |
| 85 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.85347007 |
| 86 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.84692752 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84298839 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84202760 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83642540 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82320692 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.81766746 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81656775 |
| 93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81263756 |
| 94 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80691821 |
| 95 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.80405721 |
| 96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.80405721 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.78455920 |
| 98 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.77964251 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77896066 |
| 100 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.77664503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.38327879 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.85116115 |
| 3 | MP0005671_abnormal_response_to | 3.71957964 |
| 4 | MP0003436_decreased_susceptibility_to | 3.15090269 |
| 5 | MP0001800_abnormal_humoral_immune | 3.12609460 |
| 6 | MP0000685_abnormal_immune_system | 3.02176740 |
| 7 | MP0005387_immune_system_phenotype | 2.98229206 |
| 8 | MP0001790_abnormal_immune_system | 2.98229206 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.90328275 |
| 10 | MP0009785_altered_susceptibility_to | 2.85062927 |
| 11 | MP0006082_CNS_inflammation | 2.78229740 |
| 12 | MP0002723_abnormal_immune_serum | 2.69995379 |
| 13 | MP0002419_abnormal_innate_immunity | 2.66292950 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.63180537 |
| 15 | MP0003303_peritoneal_inflammation | 2.62687702 |
| 16 | MP0005025_abnormal_response_to | 2.62509373 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.61325766 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.51118804 |
| 19 | MP0001819_abnormal_immune_cell | 2.48721748 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.28632051 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.93494751 |
| 22 | MP0000716_abnormal_immune_system | 1.91264796 |
| 23 | MP0002405_respiratory_system_inflammati | 1.88115510 |
| 24 | MP0005310_abnormal_salivary_gland | 1.86384830 |
| 25 | MP0001845_abnormal_inflammatory_respons | 1.84914179 |
| 26 | MP0002398_abnormal_bone_marrow | 1.79509038 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.77600069 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.75508692 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.75148325 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.71583445 |
| 31 | MP0009764_decreased_sensitivity_to | 1.71382695 |
| 32 | MP0001873_stomach_inflammation | 1.69438156 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.66435751 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.65907556 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.60877318 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.54390464 |
| 37 | MP0002163_abnormal_gland_morphology | 1.49867846 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.48778646 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.48548739 |
| 40 | MP0002722_abnormal_immune_system | 1.46440750 |
| 41 | MP0002429_abnormal_blood_cell | 1.45297728 |
| 42 | MP0008469_abnormal_protein_level | 1.42860958 |
| 43 | MP0003866_abnormal_defecation | 1.42226814 |
| 44 | MP0003787_abnormal_imprinting | 1.40286705 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.32077510 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.27089433 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.22433607 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.19843623 |
| 49 | MP0003195_calcinosis | 1.10984099 |
| 50 | MP0002006_tumorigenesis | 1.10438804 |
| 51 | MP0002009_preneoplasia | 1.09753048 |
| 52 | MP0004947_skin_inflammation | 1.09418598 |
| 53 | MP0001663_abnormal_digestive_system | 1.06100326 |
| 54 | MP0004381_abnormal_hair_follicle | 1.02123775 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.01847707 |
| 56 | MP0002693_abnormal_pancreas_physiology | 1.00216717 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.00173909 |
| 58 | MP0002928_abnormal_bile_duct | 0.99880764 |
| 59 | MP0003252_abnormal_bile_duct | 0.99287721 |
| 60 | MP0003045_fibrosis | 0.98884278 |
| 61 | MP0002396_abnormal_hematopoietic_system | 0.97632329 |
| 62 | MP0004883_abnormal_blood_vessel | 0.94174869 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 0.92473485 |
| 64 | MP0005379_endocrine/exocrine_gland_phen | 0.90713005 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 0.89404103 |
| 66 | MP0002933_joint_inflammation | 0.85531321 |
| 67 | MP0009763_increased_sensitivity_to | 0.84930927 |
| 68 | MP0000015_abnormal_ear_pigmentation | 0.84516766 |
| 69 | MP0005174_abnormal_tail_pigmentation | 0.82978655 |
| 70 | MP0009278_abnormal_bone_marrow | 0.77502078 |
| 71 | MP0003828_pulmonary_edema | 0.74347334 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.73910491 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.73905939 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 0.73905939 |
| 75 | MP0003646_muscle_fatigue | 0.73666025 |
| 76 | MP0002132_abnormal_respiratory_system | 0.73002623 |
| 77 | MP0008872_abnormal_physiological_respon | 0.72910711 |
| 78 | MP0005164_abnormal_response_to | 0.72221099 |
| 79 | MP0000427_abnormal_hair_cycle | 0.71706669 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.70180017 |
| 81 | MP0004043_abnormal_pH_regulation | 0.69674195 |
| 82 | MP0001853_heart_inflammation | 0.67271529 |
| 83 | MP0004142_abnormal_muscle_tone | 0.67151052 |
| 84 | MP0004130_abnormal_muscle_cell | 0.66705407 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.66063432 |
| 86 | MP0001919_abnormal_reproductive_system | 0.65475084 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.62773524 |
| 88 | MP0005166_decreased_susceptibility_to | 0.62341566 |
| 89 | MP0000858_altered_metastatic_potential | 0.62097964 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.61422432 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.60704156 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.60287798 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.58802530 |
| 94 | MP0000371_diluted_coat_color | 0.56704554 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.56110846 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.54643564 |
| 97 | MP0000343_altered_response_to | 0.54154588 |
| 98 | MP0002653_abnormal_ependyma_morphology | 0.53996496 |
| 99 | MP0008873_increased_physiological_sensi | 0.53746460 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.53711604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.87202357 |
| 2 | Optic neuritis (HP:0100653) | 4.83803263 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.83803263 |
| 4 | Stomatitis (HP:0010280) | 4.81584224 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.68191346 |
| 6 | Orchitis (HP:0100796) | 4.59945556 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.56388812 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.48715160 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.32919914 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.19528145 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.90127438 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.78350224 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.72221757 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 3.63964308 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.63964308 |
| 16 | Encephalitis (HP:0002383) | 3.48430992 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.43824943 |
| 18 | T lymphocytopenia (HP:0005403) | 3.38400149 |
| 19 | Meningitis (HP:0001287) | 3.36664316 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.33796945 |
| 21 | Recurrent skin infections (HP:0001581) | 3.32191140 |
| 22 | Vasculitis (HP:0002633) | 3.31406478 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.29564162 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.26782896 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.22256727 |
| 26 | Abnormality of T cells (HP:0002843) | 3.13283186 |
| 27 | Congenital stationary night blindness (HP:0007642) | 3.09398190 |
| 28 | Pustule (HP:0200039) | 3.05143838 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.02924975 |
| 30 | Hemoptysis (HP:0002105) | 3.01493869 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.01123470 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 2.89043693 |
| 33 | Obstructive lung disease (HP:0006536) | 2.87729354 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87729354 |
| 35 | Stomach cancer (HP:0012126) | 2.72890385 |
| 36 | Recurrent viral infections (HP:0004429) | 2.65418023 |
| 37 | IgG deficiency (HP:0004315) | 2.60842468 |
| 38 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.55386392 |
| 39 | Leukocytosis (HP:0001974) | 2.49991658 |
| 40 | Pancreatic cysts (HP:0001737) | 2.48443151 |
| 41 | Anorexia (HP:0002039) | 2.46249099 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.44862335 |
| 43 | Lymphopenia (HP:0001888) | 2.40678203 |
| 44 | Urticaria (HP:0001025) | 2.40285144 |
| 45 | Alveolar cell carcinoma (HP:0006519) | 2.38525984 |
| 46 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.37263826 |
| 47 | Chest pain (HP:0100749) | 2.35592996 |
| 48 | Hypochromic anemia (HP:0001931) | 2.34092980 |
| 49 | Episodic fever (HP:0001954) | 2.34048394 |
| 50 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.33999316 |
| 51 | Hematochezia (HP:0002573) | 2.30915631 |
| 52 | Recurrent sinusitis (HP:0011108) | 2.26498342 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.24316338 |
| 54 | Gangrene (HP:0100758) | 2.23832747 |
| 55 | Abnormality of the pleura (HP:0002103) | 2.23212669 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.22807503 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22711082 |
| 58 | Chronic otitis media (HP:0000389) | 2.15906058 |
| 59 | Arterial thrombosis (HP:0004420) | 2.15004913 |
| 60 | Attenuation of retinal blood vessels (HP:0007843) | 2.14954901 |
| 61 | Eosinophilia (HP:0001880) | 2.14444697 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.14302797 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.14280118 |
| 64 | Increased IgM level (HP:0003496) | 2.13638778 |
| 65 | Chronic diarrhea (HP:0002028) | 2.13027229 |
| 66 | Abnormality of eosinophils (HP:0001879) | 2.11495985 |
| 67 | Abnormality of the prostate (HP:0008775) | 2.10905110 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.10189793 |
| 69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08499652 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.07122457 |
| 71 | Pulmonary embolism (HP:0002204) | 2.06950587 |
| 72 | Agammaglobulinemia (HP:0004432) | 2.06792888 |
| 73 | IgM deficiency (HP:0002850) | 2.05988267 |
| 74 | Keratitis (HP:0000491) | 2.05535676 |
| 75 | Granulocytopenia (HP:0001913) | 2.04305580 |
| 76 | Pancreatic fibrosis (HP:0100732) | 2.02258156 |
| 77 | Polyneuropathy (HP:0001271) | 1.98987960 |
| 78 | Abnormality of B cell number (HP:0010975) | 1.98170553 |
| 79 | Prolonged bleeding time (HP:0003010) | 1.95195330 |
| 80 | Abnormal drinking behavior (HP:0030082) | 1.94193338 |
| 81 | Polydipsia (HP:0001959) | 1.94193338 |
| 82 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.92590808 |
| 83 | Parakeratosis (HP:0001036) | 1.92297060 |
| 84 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90916114 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 1.90428670 |
| 86 | Severe combined immunodeficiency (HP:0004430) | 1.89661443 |
| 87 | Gingivitis (HP:0000230) | 1.89478900 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86965331 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86728136 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86728136 |
| 91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86728136 |
| 92 | Cheilitis (HP:0100825) | 1.84126737 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 1.83086700 |
| 94 | Hyperventilation (HP:0002883) | 1.82846125 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 1.81606600 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.80937182 |
| 97 | Joint swelling (HP:0001386) | 1.79825867 |
| 98 | Abnormality of the endocardium (HP:0004306) | 1.79541063 |
| 99 | Abolished electroretinogram (ERG) (HP:0000550) | 1.78999915 |
| 100 | Abnormality of midbrain morphology (HP:0002418) | 1.74734060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.06436017 |
| 2 | IRAK4 | 3.49197845 |
| 3 | FRK | 3.39026404 |
| 4 | RIPK4 | 3.38421818 |
| 5 | TAOK3 | 3.29086981 |
| 6 | TXK | 3.18664106 |
| 7 | BLK | 2.58546916 |
| 8 | MAP3K14 | 2.23440103 |
| 9 | IKBKE | 2.15055741 |
| 10 | SYK | 2.13191348 |
| 11 | CSK | 2.10710420 |
| 12 | TYK2 | 2.05689740 |
| 13 | ADRBK2 | 1.92447244 |
| 14 | ACVR1B | 1.91268988 |
| 15 | BTK | 1.90888734 |
| 16 | FES | 1.90787422 |
| 17 | JAK3 | 1.87080560 |
| 18 | GRK6 | 1.81198894 |
| 19 | IKBKB | 1.77049017 |
| 20 | TLK1 | 1.68362245 |
| 21 | KIT | 1.67818656 |
| 22 | TEC | 1.66377649 |
| 23 | TNK2 | 1.66368290 |
| 24 | CSF1R | 1.64487726 |
| 25 | LYN | 1.62749836 |
| 26 | ITK | 1.58172538 |
| 27 | ZAP70 | 1.55926387 |
| 28 | IRAK1 | 1.50531640 |
| 29 | LCK | 1.43519289 |
| 30 | HCK | 1.41797153 |
| 31 | BMPR2 | 1.39347660 |
| 32 | JAK1 | 1.38897082 |
| 33 | TBK1 | 1.37280553 |
| 34 | FGR | 1.34070233 |
| 35 | MAP2K3 | 1.27570762 |
| 36 | CAMKK2 | 1.23680797 |
| 37 | PRKCQ | 1.19987616 |
| 38 | MARK3 | 1.14340773 |
| 39 | MAP4K2 | 1.14127362 |
| 40 | NLK | 1.11647955 |
| 41 | BMPR1B | 1.08343369 |
| 42 | PIK3CG | 1.08081583 |
| 43 | MATK | 1.00603394 |
| 44 | JAK2 | 0.98622208 |
| 45 | NUAK1 | 0.94845418 |
| 46 | GRK1 | 0.94569623 |
| 47 | SIK3 | 0.93985488 |
| 48 | MAP3K13 | 0.90632444 |
| 49 | OXSR1 | 0.87250858 |
| 50 | ERN1 | 0.83823396 |
| 51 | SIK2 | 0.83514754 |
| 52 | MAP3K11 | 0.81149388 |
| 53 | PTK2B | 0.80306095 |
| 54 | CHUK | 0.78165731 |
| 55 | WNK3 | 0.77644215 |
| 56 | MAP2K6 | 0.77180676 |
| 57 | PDK1 | 0.75444968 |
| 58 | ZAK | 0.74128168 |
| 59 | ADRBK1 | 0.72235630 |
| 60 | GRK7 | 0.72067873 |
| 61 | YES1 | 0.71626321 |
| 62 | WNK4 | 0.70982244 |
| 63 | STK10 | 0.65664341 |
| 64 | DAPK2 | 0.65256300 |
| 65 | PIM1 | 0.64738924 |
| 66 | EPHB1 | 0.63166983 |
| 67 | SGK2 | 0.60019938 |
| 68 | EPHA3 | 0.57309940 |
| 69 | HIPK2 | 0.54765067 |
| 70 | MAP3K7 | 0.54673217 |
| 71 | IRAK2 | 0.53411907 |
| 72 | ABL1 | 0.50058323 |
| 73 | TAOK1 | 0.48283012 |
| 74 | RPS6KA5 | 0.45536887 |
| 75 | TGFBR1 | 0.41957091 |
| 76 | TRPM7 | 0.41007884 |
| 77 | STK11 | 0.40210646 |
| 78 | FGFR3 | 0.40020330 |
| 79 | MAP3K3 | 0.39532656 |
| 80 | PRKD2 | 0.38102598 |
| 81 | RPS6KA6 | 0.37948087 |
| 82 | FYN | 0.37614460 |
| 83 | MAPKAPK2 | 0.35069358 |
| 84 | PAK3 | 0.33953338 |
| 85 | INSRR | 0.33500845 |
| 86 | PDPK1 | 0.32735576 |
| 87 | MAPK7 | 0.31876678 |
| 88 | IGF1R | 0.29909183 |
| 89 | MAP2K2 | 0.29584610 |
| 90 | PRKCZ | 0.29307578 |
| 91 | LRRK2 | 0.29130309 |
| 92 | EGFR | 0.29081900 |
| 93 | MAPK13 | 0.28514925 |
| 94 | CDC42BPA | 0.28315584 |
| 95 | MAPK11 | 0.27682724 |
| 96 | PRKCD | 0.27671226 |
| 97 | ERBB3 | 0.26664804 |
| 98 | CAMKK1 | 0.25906709 |
| 99 | MAPK12 | 0.25756241 |
| 100 | SGK3 | 0.24966978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.52098495 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.39075157 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.25937535 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.21114521 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.97434526 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.95616231 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.83217155 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75818823 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.68311185 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53293979 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15970865 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.15008163 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05424722 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05352579 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.98155747 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.90995916 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.86157045 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85703662 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.77046576 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75795417 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.71518556 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60300227 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55584105 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55020113 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.46440531 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45658306 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41630038 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39411353 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33792410 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32632733 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31472876 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.30808462 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29683570 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26065225 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21188532 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20319216 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.19765880 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18756706 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04920891 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04631819 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.02358295 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.01582322 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94769581 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91856307 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.83932987 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83412801 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81269247 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81119642 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.81025984 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.78340813 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78181157 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.77391007 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77014734 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.72934058 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72869998 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70640726 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.68535100 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.67625428 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67205851 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65464722 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61546295 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59373583 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58771679 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57321467 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54510684 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52840853 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50447896 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49581124 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49010558 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45805905 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45526877 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45360122 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43859162 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38975089 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38836307 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37356201 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37356050 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.35260255 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.34722153 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34011669 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31191808 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31164005 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30493374 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29882420 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.28221780 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27613312 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26506024 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24760807 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.23749208 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23287317 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22900223 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22375002 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21944163 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21666398 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21496405 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21307438 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.20352052 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19802053 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19768114 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.19448606 |

